Lirimilast
Product Specifications
CAS Number
329306-27-6
Target
PDE
Related Pathways
Metabolism
Bioactivity
Lirimilast is an effective, selective, and orally active phosphodiesterase-4 (PDE4) inhibitor (IC50: 49 nM) . Lirimilast has potently anti-inflammatory properties. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease.
Smiles
CS(=O)(=O)Oc1ccc2c(NC(N)=O)c(oc2c1)C(=O)c1ccc(Cl)cc1Cl
Molecular Formula
C17H12Cl2N2O6S
Molecular Weight
443.26
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
041273-ML750 100 µL
RRAGB, NT (RRAGB, Ras-related GTP-binding protein B) (MaxLight 750) discontinued
Sign In for Pricing
View Details 129710-APC 100 µL
MKRN2 (RNF62, Probable E3 Ubiquitin-protein Ligase Makorin-2, RING Finger Protein 62, HSPC070) (APC)
Sign In for Pricing
View Details 
TRV-0034848-01 20 µL
Monoclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
Sign In for Pricing
View Details TRV-0034848-02 100 µL
Monoclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
Sign In for Pricing
View Details